There is not enough evidence to call Cameco stock a bargain—or to recommend selling just because it has fallen. The cited company disclosures show mixed results and a higher 2026 uranium-price outlook, but they do not verify the headline’s 24% share-price decline or establish whether the shares are attractively valued today. The decision depends on the actual price move, what the market already expects, and your view of Cameco’s uranium and Westinghouse businesses.
Is Cameco stock really down 24% over three months?
The 24% figure cannot be verified from the evidence available here: it does not include a dated historical price series or specify the start and end dates, listing, currency, or adjusted-price method. Cameco trades in Canada as CCO and in the United States as CCJ, so the percentage may differ depending on which listing and currency are used. Its July 31, 2026, quarterly disclosures do not establish what the share price did during the subsequent period.
That distinction matters. A price drop is not, by itself, evidence of a change in Cameco’s business or proof that the stock is cheap. To assess the claimed move, compare closing prices on clearly stated dates for the same listing and currency, and specify whether the calculation includes distributions or other price adjustments. Do not attribute the decline to any one company development without evidence linking the two.
What Cameco’s latest reported results say
Cameco’s latest results in the cited material are for the quarter ended June 30, 2026, released July 31. Consolidated Q2 net earnings were C$25 million, adjusted net earnings were C$77 million, and adjusted EBITDA was C$391 million. For the first half of 2026, those measures were C$156 million, C$281 million, and C$899 million, respectively. Adjusted net earnings and adjusted EBITDA are non-IFRS measures. Cameco said its lower comparative results were primarily driven by lower equity earnings from Westinghouse. (Cameco Q2 2026 release)
The Tool Desk
Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →#1 Best Overall
The segments help explain why the quarter is not a simple uranium-price story. Cameco reported lower year-over-year Q2 uranium-segment results as well as sharply lower Westinghouse equity earnings. The figures below are issuer-reported; neither segment comparison alone determines the shares’ value.
| Business measure | Q2 2026 | Q2 2025 | Context |
| Uranium earnings before taxes | C$170 million | C$281 million | Cameco cited normal delivery variation and lower planned 2026 sales deliveries in the comparison; it also reported improving realized prices on market-related contracts. |
| Uranium adjusted EBITDA | C$252 million | C$352 million | A quarterly result affected by delivery volumes and the sales mix, not just the quoted uranium market price. |
| Westinghouse net earnings (loss) attributable to Cameco | C$10 million loss | C$126 million earnings | Cameco said the earlier quarter included a contribution from the Dukovany project. |
| Cameco’s share of Westinghouse adjusted EBITDA | C$163 million | C$352 million | The year-over-year comparison reflects weaker equity earnings and project-related timing effects. |
Source for the table: Cameco Q2 2026 release. The company’s adjusted measures are non-IFRS measures.
Rank #2
- Ideal for Gifting
- Ideal for a bookworm
- Compact for travelling
How uranium prices reach Cameco’s results
Cameco does not sell every pound at the current spot price. Its contracts use different pricing mechanisms, and deliveries, purchases, and inventory influence when market conditions show up in reported results. The company also buys uranium to meet customer commitments, so a higher market price can affect purchase costs as well as realized selling prices. Its 2025 annual report discusses the effects of its contract portfolio and purchase terms on price sensitivity.
For Q2 2026, Cameco reported 7.1 million pounds of uranium deliveries, 3.9 million pounds of production attributable to the company, and purchases of 2.8 million pounds at an average C$91.40 per pound (US$66.60). It held 8.7 million pounds of uranium inventory at June 30, 2026, at an average inventory cost of C$58.05 per pound. These are company-reported period figures; they do not, by themselves, show what future deliveries will cost or what margins will be. (Cameco Q2 2026 report)
Cameco described stronger long-term uranium prices and increased contracting activity during the first half of 2026 as customers emphasized security of supply. That is management’s characterization, not an independent market-price series. It reported average annual delivery commitments exceeding 28 million pounds over the next five years, with commitments above average in 2026–28 and below average in 2029–30. Cameco said it expected to add further volumes using market-related pricing. (Cameco Q2 2026 release; Cameco Q2 2026 report)
What management expects for 2026
In its July 2026 outlook, Cameco maintained its uranium production guidance and raised its revenue and average realized uranium-price outlook. Those estimates depend on carrying out the production plan and sourcing and delivering required material; they are guidance, not guaranteed results.
Rank #4
| 2026 outlook measure | Company guidance as of July 2026 |
| Uranium production attributable to Cameco | 19.5–21.5 million pounds |
| Consolidated revenue | C$3.32–3.57 billion |
| Uranium revenue | C$2.70–2.91 billion |
| Average realized uranium price | C$91–96 per pound |
| Average uranium unit cost of sales | C$63–67.50 per pound |
Cameco’s July 2026 MD&A used a 1.35 USD/CAD exchange-rate assumption for the remainder of 2026. The company said temporary disruptions at Key Lake and McArthur River, followed later by disruptions at Cigar Lake, had not changed its production guidance as of the Q2 report. The guidance and exchange-rate assumption are company estimates, not outcomes already achieved. (Cameco Q2 2026 MD&A; Cameco Q2 2026 report)
Why Westinghouse matters to the stock case
Cameco’s consolidated results include its share of Westinghouse, so the company’s earnings are exposed to more than uranium mining and sales. Westinghouse’s Q2 comparison was affected by the Dukovany contribution in the prior-year quarter, while future reactor projects bring timing and execution uncertainty. Cameco’s 2025 annual-report outlook for Westinghouse also depended on definitive agreements and U.S. government funding or support for reactor deployments. Those dependencies make new-build expectations different from established, recurring earnings. (Cameco 2025 annual report)
Best Value
- It can be a gift option
- Comes with secure packaging
- Helpful in various ways
When buying, holding, or selling could make sense
A useful choice compares the options using the same assumptions and time horizon. A decline may improve a prospective return only if the price has fallen more than the business outlook and risks justify; it does not establish that on its own.
| Choice | Could fit if… | What to check first |
| Buy or add | You believe long-term uranium demand and Cameco’s contract position can support future cash generation, and you can tolerate operating and commodity-linked volatility. | Whether the current share price is reasonable relative to normalized earnings or cash flow; production delivery, purchase costs, contract pricing, and Westinghouse assumptions. |
| Hold | Your original investment case remains intact, your position still fits your risk tolerance, and you do not need the money on a short timetable. | Whether new operating or project information changes your original assumptions, and whether Cameco has become too large a share of your portfolio. |
| Sell or trim | Your investment case has weakened, the position is too concentrated, or you need to reduce exposure to uncertainty or free up cash. | Whether the reason is a fundamental change or a short-term price move; also consider tax consequences and the risk of selling before a recovery. |
The evidence cited here does not provide a current market capitalization, enterprise value, fair value, price target, analyst consensus, or peer comparison. It therefore cannot establish that Cameco is cheap or expensive at the current price. Any valuation comparison should use a dated share price and consistent measures for Cameco and comparable companies, rather than treating the 24% figure as a valuation signal.
Risks to weigh before acting
- Production and delivery: Mine, mill, transport, labor, or sourcing problems can affect planned output and customer deliveries; guidance can change.
- Contract and purchase economics: Contract pricing, delivery timing, and the terms and cost of purchased material can make the effect of uranium-market moves uneven.
- Westinghouse execution: Project timing, agreements, funding, and delivery affect the contribution from this business.
- Currency and listing: Cameco reports mainly in Canadian dollars but its shares also trade in U.S. dollars. Exchange-rate movements can change an investor’s return in their home currency.
- Financial capacity versus operating risk: At June 30, 2026, Cameco reported C$1.1 billion in cash, C$1.0 billion in total debt, and a C$1.0 billion undrawn revolving credit facility. Those balances provide liquidity context but do not remove price, execution, or valuation risk. (Cameco Q2 2026 release)
A practical decision check
- Confirm the actual three-month move for CCO or CCJ, stating the dates, currency, and price-adjustment method.
- Write down what would change your view of Cameco’s production, uranium contract economics, and Westinghouse contribution; use the July 2026 outlook as a dated company forecast, not a promise.
- Estimate whether the current price compensates you for those risks using a valuation method and dated inputs you can explain. No such valuation is established by the company results alone.
- Check your position size, diversification, time horizon, cash needs, and ability to withstand further volatility before deciding whether to add, hold, or trim.
On the evidence available through Cameco’s Q2 2026 reporting, there is a mixed operating picture rather than a clear buy-or-sell signal. A decision should rest on verified share-price data, a valuation at that price, and your own view of the company’s execution and risk—not the unverified drawdown alone.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
